title: Pharmacokinetics of monepantel and its sulfone metabolite, monepantel sulfone, after intravenous and oral administration in sheep.
abstract: The pharmacokinetic properties of the developmental Amino-Acetonitrile Derivative (AAD), monepantel and its sulfone metabolite, monepantel sulfone were investigated in sheep following intravenous (i.v.) and oral administrations. The sulfone metabolite was rapidly formed and predominated over monepantel 4 h after dosing, irrespective of the route of administration. The steady-state volume of distribution, total body clearance and mean residence time of monepantel were 7.4 L/kg, 1.49 L/(kg x h) and 4.9 h, respectively and 31.2 L/kg, 0.28 L/(kg x h) and 111 h, respectively for monepantel sulfone. The overall bioavailability of monepantel was 31%, but it was demonstrated that approximately the same amount of monepantel sulfone was produced whether monepantel was given intravenously or orally (AUC((0-infinity)) oral/AUC((0-infinity)) i.v. of 94% for monepantel sulfone), making oral administration a very efficient route of administration for monepantel in terms of the amount of sulfone metabolite generated. Because monepantel sulfone is the main chemical entity present in sheep blood after monepantel administration and because it is also an active metabolite, its pharmacokinetic properties are of primary importance for the interpretation of future residue and efficacy studies. Overall, these pharmacokinetic data aid in the evaluation of monepantel as an oral anthelmintic in sheep.
authors.affiliation: Novartis Animal Health Australasia Pty Limited, Yarrandoo R & D Centre, New South Wales, Australia.
authors.forename: D
authors.initials: D
authors.lastname: Karadzovska
authors.forename: W
authors.initials: W
authors.lastname: Seewald
authors.forename: A
authors.initials: A
authors.lastname: Browning
authors.forename: M
authors.initials: M
authors.lastname: Smal
authors.forename: J
authors.initials: J
authors.lastname: Bouvier
authors.forename: J M
authors.initials: JM
authors.lastname: Giraudel
mesh_terms: D000284:Administration, Oral; D000607:Aminoacetonitrile / Q000031:analogs & derivatives* / Q000097:blood / Q000493:pharmacokinetics; D000818:Animals; D000871:Anthelmintics / Q000493:pharmacokinetics; D001682:Biological Availability; D002851:Chromatography, High Pressure Liquid; D005243:Feces / Q000737:chemistry; D005260:Female; D007262:Infusions, Intravenous / Q000662:veterinary; D008297:Male; D012756:Sheep / Q000097:blood / Q000378:metabolism* / Q000652:urine; D013450:Sulfones / Q000097:blood / Q000493:pharmacokinetics*; D054928:Validation Studies as Topic
chemical_list: D000871:Anthelmintics; D013450:Sulfones; C553923:monepantel sulfone; D000607:Aminoacetonitrile; C533978:monepantel